IP Library Granted Patent US 12,432,987
Granted Patent B2
US 12,432,987 · App. 18/323,325 · Granted Sep 30, 2025

High dose implantation for ultrathin semiconductor-on-insulator substrates

Inventor: Jocelyne Gimbert (Crolles, FR)
Assignee: STMICROELECTRONICS, INC.
H10D30/797H01L21/26506H01L21/26513H01L21/324H01L21/707H10D30/0275H10D30/0323H10D62/832H10D62/8325H10D84/0167H10D84/017H10D84/038H10D86/01H10D86/201H10D30/024H10D62/822
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,432,987
App. No.
18/323,325
Granted
Sep 30, 2025
Kind
B2
Abstract

Methods and structures for forming highly-doped, ultrathin layers for transistors formed in semiconductor-on-insulator substrates are described. High dopant concentrations may be achieved in ultrathin semiconductor layers to improve device characteristics. Ion implantation at elevated temperatures may mitigate defect formation for stoichiometric dopant concentrations up to about 30%. In-plane stressors may be formed adjacent to channels of transistors formed in ultrathin semiconductor layers.

Claims (53)

1. An integrated circuit, comprising:

a substrate;

an insulating layer over the substrate;

an ultrathin semiconductor layer on the insulating layer, the ultrathin semiconductor layer having a first surface and a second surface opposite the first surface, the ultrathin semiconductor layer including a first portion and a second portion, the first portion and the second portion both extending from the first surface to the second surface;

a first device former in and over the first portion, the first device including:

a first gate structure over the first portion

a first channel region embedded in the first portion and below the first gate structure, the first channel region including a first doping concentration of a first impurity, the first impurity is germanium, and

a first source or drain extension region embedded in the first portion and laterally adjacent to the first channel region, the first source or drain extension region including a second doping concentration of the first impurity, the second doping concentration being greater than the first doping concentration; and

a second device formed in and over the second portion, the second device including:

a second gate structure over the second portion,

a second channel region embedded in the second portion and below the second gate structure, the second channel region being substantially un-doped, and

a second source or drain extension region embedded in the second portion and laterally adjacent to the second channel region, the second source or drain extension region including a third doping concentration of a second impurity,

wherein the ultrathin semiconductor layer includes silicon.

2. The integrated circuit of claim 1 , wherein a thickness of the ultrathin semiconductor layer is less than approximately 10 nm.

3. The integrated circuit of claim 1 , wherein the second source or drain extension region applies a compressive tension toward the second channel region.

4. The integrated circuit of claim 1 , wherein the first and second devices are transistors.

5. A method, comprising:

forming an ultrathin semiconductor layer on an insulating layer over a substrate, the ultrathin semiconductor layer having a first surface and a second surface opposite the first surface, the ultrathin semiconductor layer including a first portion and a second portion, the first portion and the second portion both extending from the first surface to the second surface;

forming a first device in and over the first portion, the first device including:

a first gate structure over the first portion,

a first channel region embedded in the first portion and below the first gate structure, the first channel region including a first doping concentration of a first impurity, the first impurity is germanium, and

a first source or drain extension region embedded in the first portion and laterally adjacent to the first channel region, the first source or drain extension region including a second doping concentration of the first impurity, the second doping concentration being greater than the first doping concentration; and

forming a second device in and over the second portion, the second device including:

a second gate structure over the second portion,

a second channel region embedded in the second portion and below the second gate structure, and the second channel region being substantially un-doped,

a second source or drain extension region embedded in the second portion and laterally adjacent to the second channel region, the second source or drain extension region including a third doping concentration of a second impurity,

wherein the ultrathin semiconductor layer includes silicon.

6. The method of claim 5 , further comprising doping the first portion by implanting a first dopant of the first impurity.

7. The method of claim 6 , further comprising:

before doping the first portion, forming a thin implantation layer over the first portion; and

removing the thin implantation layer after implanting the first dopant, wherein the first dopant is implanted through the thin implantation layer.

8. The method of claim 7 , further comprising:

before forming the thin implantation layer, forming a hardmask over the second portion; and

removing the hardmask after the implanting the first dopant.

9. The method of claim 7 , wherein the thin implantation layer is an oxide layer, a thin nitride layer, a thin polymer layer, or a thin low-Z metal layer.

10. The method of claim 6 , wherein doping includes maintaining the substrate at a temperature between approximately 350° C. and approximately 500° C.

11. The method of claim 6 , wherein implanting the first dopant is carried out at an energy between approximately 0.5 keV and approximately 3 keV.

12. The method of claim 6 , wherein the first dopant is implanted at a dose between approximately 0.5×10 16 cm −2 and approximately 2×10 16 cm −2 .

13. A device, comprising:

a substrate;

an insulating layer on the substrate;

a silicon ultrathin semiconductor layer on the insulating layer, the silicon ultrathin semiconductor layer having a first surface opposite a second surface, the silicon ultrathin semiconductor layer including a first portion and a second portion, the first portion and the second portion both extending from the first surface to the second surface;

a first transistor on the first portion, the first transistor including:

a first gate structure on the first portion,

a doped channel in the first portion and opposite the first gate structure, the second channel region being substantially un-doped, and

a first doped source or drain extension region in the first portion and spaced from the doped channel, the first doped source or drain extension region have a first doping concentration greater than a second doping concentration of the doped channel; and

a second transistor on the second portion and spaced from the first transistor, the second transistor including:

a second gate structure on the second portion,

an un-doped channel in the second portion and opposite the second gate structure, and

a second doped source or drain extension region in the second portion and spaced from to the un-doped channel.

14. The device of claim 13 , wherein the doped channel and the first portion are coplanar.

15. The device of claim 13 , wherein the un-doped channel and the second portion are coplanar.

16. The device of claim 13 , wherein the doped channel has a concentration of germanium from about 15% to about 40%.

Continuity (4)
Division 16168771 · Oct 23, 2018
Continuation 14982052 · Dec 29, 2015
Division 14169875 · Jan 31, 2014
Related Publication 20230299202A1 · Sep 21, 2023
References Cited (100)
US 4176372A · Matsushita et al. · 1979 [cited by applicant]
US 5116771A · Karulkar · 1992 [cited by applicant]
US 6194255B1 · Hiroki et al. · 2001 [cited by applicant]
US 6403433B1 · Yu et al. · 2002 [cited by applicant]
US 6503805B2 · Wang et al. · 2003 [cited by applicant]
US 6528851B1 · Yu · 2003 [cited by applicant]
US 6709913B2 · Hsu · 2004 [cited by applicant]
US 6797555B1 · Hopper et al. · 2004 [cited by applicant]
US 6812523B1 · Chu et al. · 2004 [cited by applicant]
US 6849527B1 · Xiang · 2005 [cited by applicant]
US 6987037B2 · Forbes · 2006 [cited by applicant]
US 7002214B1 · Boyd et al. · 2006 [cited by applicant]
US 7005333B2 · Li · 2006 [cited by applicant]
US 7081657B2 · Faris · 2006 [cited by applicant]
US 7115955B2 · Messenger et al. · 2006 [cited by applicant]
US 7247569B2 · Boyd et al. · 2007 [cited by applicant]
US 7417248B2 · Li · 2008 [cited by applicant]
US 7687356B2 · Coronel et al. · 2010 [cited by applicant]
US 7736996B2 · Theodore et al. · 2010 [cited by applicant]
US 7968459B2 · Bedell et al. · 2011 [cited by applicant]
US 7989306B2 · Liu et al. · 2011 [cited by applicant]
US 8110483B2 · Abadeer et al. · 2012 [cited by applicant]
US 8329557B2 · Brailove et al. · 2012 [cited by applicant]
US 8426920B2 · Zhu et al. · 2013 [cited by applicant]
US 8492854B1 · Cheng et al. · 2013 [cited by applicant]
US 8603894B2 · Majumdar et al. · 2013 [cited by applicant]
US 8673699B2 · Adam et al. · 2014 [cited by applicant]
US 8748258B2 · Cheng et al. · 2014 [cited by applicant]
US 8877620B2 · Clark · 2014 [cited by applicant]
US 8890264B2 · Dewey et al. · 2014 [cited by applicant]
US 8900973B2 · Berliner et al. · 2014 [cited by applicant]
US 8941178B2 · Yamamoto et al. · 2015 [cited by applicant]
US 8987069B1 · Adam et al. · 2015 [cited by applicant]
US 9023713B2 · Illgen · 2015 [cited by examiner]
US 9059212B2 · Haensch et al. · 2015 [cited by applicant]
US 9123642B1 · Lee et al. · 2015 [cited by applicant]
US 9171757B2 · Doris et al. · 2015 [cited by applicant]
US 9406751B2 · Liu et al. · 2016 [cited by applicant]
US 9466720B2 · Liu et al. · 2016 [cited by applicant]
US 9607901B2 · Liu et al. · 2017 [cited by applicant]
US 9634103B2 · Vinet et al. · 2017 [cited by applicant]
US 10115803B2 · Quay et al. · 2018 [cited by applicant]
US 20020125502A1 · Baba et al. · 2002 [cited by applicant]
US 20030080361A1 · Murthy et al. · 2003 [cited by applicant]
US 20030146494A1 · Puchner et al. · 2003 [cited by applicant]
US 20040046209A1 · Sera · 2004 [cited by examiner]
US 20040129979A1 · Park et al. · 2004 [cited by applicant]
US 20050055494A1 · Doris et al. · 2005 [cited by applicant]
US 20050112811A1 · Hsu et al. · 2005 [cited by applicant]
US 20050285192A1 · Zhu · 2005 [cited by applicant]
US 20060006469A1 · Hwang · 2006 [cited by applicant]
US 20060134872A1 · Hattendorf et al. · 2006 [cited by applicant]
US 20060148150A1 · Kavalieros et al. · 2006 [cited by applicant]
US 20070178689A1 · Nakamura et al. · 2007 [cited by applicant]
US 20070257315A1 · Bedell et al. · 2007 [cited by applicant]
US 20080185665A1 · Liaw et al. · 2008 [cited by applicant]
US 20080217686A1 · Majumdar et al. · 2008 [cited by applicant]
US 20080283918A1 · Cheng et al. · 2008 [cited by applicant]
US 20080311732A1 · Dokumaci et al. · 2008 [cited by applicant]
US 20090045462A1 · Ren et al. · 2009 [cited by applicant]
US 20090057672A1 · Kobayashi et al. · 2009 [cited by applicant]
US 20090065784A1 · Kobayashi et al. · 2009 [cited by applicant]
US 20090289305A1 · Majumdar et al. · 2009 [cited by applicant]
US 20100032684A1 · Bedell et al. · 2010 [cited by applicant]
US 20100279479A1 · Hatem et al. · 2010 [cited by applicant]
US 20110037125A1 · Cheng et al. · 2011 [cited by applicant]
US 20110095366A1 · Abadeer et al. · 2011 [cited by applicant]
US 20110227157A1 · Yang et al. · 2011 [cited by applicant]
US 20110291100A1 · Cheng et al. · 2011 [cited by applicant]
US 20110291189A1 · Cheng et al. · 2011 [cited by applicant]
US 20120104498A1 · Majumdar et al. · 2012 [cited by applicant]
US 20120139047A1 · Luo et al. · 2012 [cited by applicant]
US 20120146142A1 · Zhu et al. · 2012 [cited by applicant]
US 20120156847A1 · Loubet et al. · 2012 [cited by applicant]
US 20120235215A1 · Flachowsky et al. · 2012 [cited by applicant]
US 20120313168A1 · Cheng et al. · 2012 [cited by applicant]
US 20130015525A1 · Cheng et al. · 2013 [cited by applicant]
US 20130052801A1 · Berliner et al. · 2013 [cited by applicant]
US 20130056766A1 · Hotta · 2013 [cited by applicant]
US 20130069164A1 · Marino et al. · 2013 [cited by applicant]
US 20130099319A1 · Adam et al. · 2013 [cited by applicant]
US 20130146959A1 · Cheng et al. · 2013 [cited by applicant]
US 20130153964A1 · Guo et al. · 2013 [cited by applicant]
US 20130341722A1 · Illgen et al. · 2013 [cited by applicant]
US 20140024181A1 · Adam et al. · 2014 [cited by applicant]
US 20140048886A1 · Chuang et al. · 2014 [cited by applicant]
US 20140099763A1 · Alptekin et al. · 2014 [cited by applicant]
US 20140167164A1 · Adam et al. · 2014 [cited by applicant]
US 20140203363A1 · Adam et al. · 2014 [cited by applicant]
US 20140284719A1 · Khakifirooz et al. · 2014 [cited by applicant]
US 20140312423A1 · Cheng et al. · 2014 [cited by applicant]
US 20150093861A1 · Loubet et al. · 2015 [cited by applicant]
US 20150221648A1 · Gimbert · 2015 [cited by applicant]
US 20150228501A1 · Bedell et al. · 2015 [cited by applicant]
US 20160093735A1 · Dittmar et al. · 2016 [cited by applicant]
US 20160155844A1 · Yin et al. · 2016 [cited by applicant]
CN 103367430A · 2016 [cited by applicant]
Peter V. Schwartz, “Oxygen Incorporation During Low-Temperature Chemical Vapor Deposition and Its Effects on The Electronic Properties of Epitaxial Si and Sil-xGex Films”, A Dissertation Presented to The Faculty of Prin… [cited by applicant]
Saenger et al., “Effect of Elevated Implant Temperature on Amorphization and Activation in As-implanted Silicon-on-insulator Layers,” [cited by applicant]
Saenger et al., “Effect of Elevated Implant Temperature on Amorphization and Activation in As-implanted Silicon-on-insulator Layers”, Mater. Res. Soc. Symp. Proc. vol. 1070 © 2008 Materials Research Society 1070-E05-02;. [cited by applicant]